zoledronic acid has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Nagamine, I; Ohara, M; Okada, M; Yamaguchi, Y | 1 |
| Cao, JY; Chen, YQ; Cui, SX; Gao, HJ; Gao, J; Guo, CH; Liu, T; Mi, YJ; Qiu, GQ; Xie, JD; Yao, SP; Zhang, YY | 1 |
2 other study(ies) available for zoledronic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Topics: Antineoplastic Agents; Case-Control Studies; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Colorectal Neoplasms; Diphosphonates; Esophageal Neoplasms; Humans; Imidazoles; Immunotherapy, Adoptive; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Neoplasm Metastasis; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid | 2009 |
Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chromosomal Proteins, Non-Histone; Cisplatin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Esophageal Neoplasms; Esophagus; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Microfilament Proteins; Middle Aged; Neoplasm Staging; Prognosis; Proportional Hazards Models; Sex Factors; Survival Rate; Zoledronic Acid | 2013 |